At EY, we’re all in to shape your future with confidence. We’ll help you succeed in a globally connected powerhouse of diverse teams and take your career wherever you want it to go. Join EY and
At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our
Responsibilities Support Quality Team’s operations and site quality objectives. Assess and evaluate Domestic suppliers per local and global supplier quality procedure. Coordinate with Japan suppliers on applicable quality related customer complaints and develop applicable corrective actions.
job title: SAITAMA QUALITY EXPERT (Quality Assurance) 1. Quality Assurance: We seamlessly supply high quality products to the Japanese market. Develop and maintain the latest quality system at Saitama site and ensure that the quality system
Working location: Ibaraki Policies, Procedures and Standards (40%) Implement and enforce policies, procedures and standards Conduct internal site audits, document audit results and ensure site audit preparedness Maintain knowledge and understanding of applicable GMP regulations, regulatory
Position Summary & Job Description Quality Operations Specialist (Component) is responsible for quality assurance activities related, but not limited to, packaging components to be used in the site manufacturing operation through the material incoming inspection with
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
At EY, we’re all in to shape your future with confidence. We’ll help you succeed in a globally connected powerhouse of diverse teams and take your career wherever you want it to go. Join EY and
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
At EY, we’re all in to shape your future with confidence. We’ll help you succeed in a globally connected powerhouse of diverse teams and take your career wherever you want it to go. Join EY and